Upgrade to SI Premium - Free Trial

Soleno Therapeutics (SLNO)

53.01 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26 *Est.)

Latest Headlines

Form 15-12G SOLENO THERAPEUTICS INC May 28, 2026 4:49 PM - SEC Filing Form EFFECT SOLENO THERAPEUTICS INC May 28, 2026 6:04 AM - SEC Filing Form POS AM SOLENO THERAPEUTICS INC May 21, 2026 4:16 PM - SEC Filing Form AW SOLENO THERAPEUTICS INC May 21, 2026 4:07 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Yen Kristen May 18, 2026 4:53 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Volck Birgitte May 18, 2026 4:49 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Sinclair Andrew May 18, 2026 4:47 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Pauls Matthew May 18, 2026 4:45 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Norrett Kevin May 18, 2026 4:43 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Manning Meredith May 18, 2026 4:42 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Joshi Manher May 18, 2026 4:40 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Huang Michael F. May 18, 2026 4:38 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Hirano Patricia C May 18, 2026 4:37 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Hahn Mark W May 18, 2026 4:35 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Fulk Jennifer May 18, 2026 4:33 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Bir Dawn Carter May 18, 2026 4:29 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: May 18 Filed by: Anish Bhatnagar May 18, 2026 4:29 PM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:29 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:27 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:27 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:25 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:25 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:25 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:23 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:22 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:21 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:20 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:19 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:19 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:19 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:18 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:18 AM - SEC Filing Form S-8 POS SOLENO THERAPEUTICS INC May 18, 2026 9:18 AM - SEC Filing Form POSASR SOLENO THERAPEUTICS INC May 18, 2026 9:12 AM - SEC Filing Form POSASR SOLENO THERAPEUTICS INC May 18, 2026 9:09 AM - SEC Filing Form 25-NSE SOLENO THERAPEUTICS INC Filed by: Nasdaq Stock Market LLC May 18, 2026 9:07 AM - SEC Filing Form 8-K SOLENO THERAPEUTICS INC For: May 18 May 18, 2026 9:07 AM - SEC Filing Form SC 14D9/A SOLENO THERAPEUTICS INC Filed by: SOLENO THERAPEUTICS INC May 18, 2026 9:04 AM - SEC Filing Form SC TO-T/A SOLENO THERAPEUTICS INC Filed by: NEUROCRINE BIOSCIENCES INC May 18, 2026 8:57 AM - SEC Filing Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: PRICE T ROWE ASSOCIATES INC /MD/ May 15, 2026 10:09 AM - SEC Filing Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Avoro Capital Advisors LLC May 15, 2026 8:19 AM - SEC Filing Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP May 15, 2026 7:07 AM - SEC Filing Form SCHEDULE 13G SOLENO THERAPEUTICS INC Filed by: STATE STREET CORP May 12, 2026 12:02 PM - SEC Filing Form 10-Q SOLENO THERAPEUTICS INC For: Mar 31 May 7, 2026 4:45 PM - SEC Filing Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: JANUS HENDERSON GROUP PLC May 7, 2026 11:30 AM - SEC Filing Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: FMR LLC May 7, 2026 10:33 AM - SEC Filing Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: FMR LLC May 6, 2026 11:44 AM - SEC Filing Form 10-K/A SOLENO THERAPEUTICS INC For: Dec 31 April 30, 2026 4:43 PM - SEC Filing Form SC TO-T/A SOLENO THERAPEUTICS INC Filed by: NEUROCRINE BIOSCIENCES INC April 29, 2026 4:33 PM - SEC Filing Form SC 14D9/A SOLENO THERAPEUTICS INC Filed by: SOLENO THERAPEUTICS INC April 28, 2026 7:31 AM - SEC Filing Form SC TO-T/A SOLENO THERAPEUTICS INC Filed by: NEUROCRINE BIOSCIENCES INC April 28, 2026 7:31 AM - SEC Filing Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: BlackRock, Inc. April 24, 2026 4:14 PM - SEC Filing Shareholder Alert: The Ademi Firm investigates whether Soleno Therapeutics Inc.’s Transaction with Neurocrine is Fair to Public Shareholders April 23, 2026 8:08 AM - StreetInsider Form SC 14D9 SOLENO THERAPEUTICS INC Filed by: SOLENO THERAPEUTICS INC April 20, 2026 8:54 AM - SEC Filing Form SC TO-T SOLENO THERAPEUTICS INC Filed by: NEUROCRINE BIOSCIENCES INC April 20, 2026 7:37 AM - SEC Filing Wells Fargo Downgrades Soleno Therapeutics Inc. (SLNO) to Equal Weight April 17, 2026 5:14 AM - StreetInsider Folia Health Launches “BRAVE-PWS” Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers April 15, 2026 8:01 AM - Globe NewsWire Neurocrine Bio. (NBIX) PT Raised to $185 at Morgan Stanley April 10, 2026 6:06 AM - StreetInsider Increasing unusual put option volume: SLNO VIAV XLC XLY TSEM ENTG SCO LYB CAR AEHR CWAN LAES EXE NEXT LEVI April 9, 2026 2:03 AM - StreetInsider H.C. Wainwright Downgrades Soleno Therapeutics Inc. (SLNO) to Neutral April 8, 2026 6:05 AM - StreetInsider Form 8-K SOLENO THERAPEUTICS INC For: Apr 07 April 7, 2026 12:42 PM - SEC Filing Form SC TO-C SOLENO THERAPEUTICS INC Filed by: NEUROCRINE BIOSCIENCES INC April 7, 2026 11:42 AM - SEC Filing Piper Sandler Downgrades Soleno Therapeutics Inc. (SLNO) to Neutral April 7, 2026 8:42 AM - StreetInsider Soleno withdraws European application for Prader-Willi syndrome drug April 7, 2026 7:08 AM - StreetInsider TD Cowen Downgrades Soleno Therapeutics Inc. (SLNO) to Hold April 7, 2026 2:57 AM - StreetInsider Stifel Downgrades Soleno Therapeutics Inc. (SLNO) to Hold April 7, 2026 2:34 AM - StreetInsider Form SC14D9C SOLENO THERAPEUTICS INC Filed by: SOLENO THERAPEUTICS INC April 6, 2026 5:18 PM - SEC Filing Form SC TO-C SOLENO THERAPEUTICS INC Filed by: NEUROCRINE BIOSCIENCES INC April 6, 2026 5:08 PM - SEC Filing Wolfe Research Downgrades Soleno Therapeutics Inc. (SLNO) to Peerperform April 6, 2026 4:07 PM - StreetInsider Oppenheimer Downgrades Soleno Therapeutics Inc. (SLNO) to Perform April 6, 2026 4:02 PM - StreetInsider Neurocrine Bio. (NBIX) PT Raised to $200 at Canaccord April 6, 2026 2:41 PM - StreetInsider Baird Downgrades Soleno Therapeutics Inc. (SLNO) to Neutral April 6, 2026 2:06 PM - StreetInsider Neurocrine Bio. (NBIX) PT Raised to $220 at Oppenheimer on SLNO deal April 6, 2026 1:59 PM - StreetInsider Laidlaw Downgrades Soleno Therapeutics Inc. (SLNO) to Hold April 6, 2026 12:27 PM - StreetInsider Cantor Fitzgerald Downgrades Soleno Therapeutics Inc. (SLNO) to Neutral April 6, 2026 8:45 AM - StreetInsider Form 8-K SOLENO THERAPEUTICS INC For: Apr 05 April 6, 2026 7:47 AM - SEC Filing Form SC TO-C SOLENO THERAPEUTICS INC Filed by: NEUROCRINE BIOSCIENCES INC April 6, 2026 7:40 AM - SEC Filing Soleno Therapeutics (SLNO) to Resume Trading at 7:30 am April 6, 2026 7:11 AM - StreetInsider Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout April 6, 2026 7:07 AM - StreetInsider Neurocrine to acquire Soleno Therapeutics for $2.9 billion in cash deal April 6, 2026 7:01 AM - StreetInsider Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio April 6, 2026 7:00 AM - PR NewsWire Soleno Therapeutics (SLNO) Halted, News Pending April 6, 2026 6:57 AM - StreetInsider Neurocrine Biosciences nearing over $2.5B deal for Soleno Therapeutics April 6, 2026 5:53 AM - StreetInsider Form 4 SOLENO THERAPEUTICS INC For: Mar 27 Filed by: Manning Meredith March 31, 2026 8:17 PM - SEC Filing Form 4 SOLENO THERAPEUTICS INC For: Mar 27 Filed by: Huang Michael F. March 31, 2026 8:16 PM - SEC Filing Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): March 30, 2026 9:49 AM - StreetInsider Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: VANGUARD GROUP INC March 27, 2026 1:17 PM - SEC Filing Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): March 25, 2026 8:24 AM - StreetInsider Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law March 23, 2026 8:55 AM - StreetInsider Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law March 20, 2026 9:42 AM - StreetInsider DEADLINE ALERT for EOSE, SLNO, NKTR, DRVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions March 19, 2026 1:28 PM - Globe NewsWire DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders March 19, 2026 12:08 PM - Globe NewsWire Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors March 19, 2026 9:01 AM - Globe NewsWire Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDA March 18, 2026 9:17 AM - Globe NewsWire Soleno Therapeutics Inc. (SLNO) PT Lowered to $80 at Oppenheimer March 18, 2026 6:03 AM - StreetInsider Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline March 17, 2026 10:50 PM - Globe NewsWire SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm March 17, 2026 9:01 AM - PR NewsWire Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNC March 16, 2026 9:32 AM - StreetInsider Form 8-K SOLENO THERAPEUTICS INC For: Mar 16 March 16, 2026 9:29 AM - SEC Filing Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO March 16, 2026 3:03 AM - PR NewsWire Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); EOS Energy Enterprise, Inc. (NASDAQ: EOSE); and Soleno Therapeutics, Inc. (NASDAQ: SLNO) March 14, 2026 12:29 PM - Globe NewsWire Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline March 13, 2026 10:14 PM - PR NewsWire Notice to Long-Term Investors of Soleno Therapeutics, Inc. (SLNO): Grabar Law Office Investigates Claims on Your Behalf March 13, 2026 6:30 PM - StreetInsider DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders March 13, 2026 12:08 PM - Globe NewsWire SLNO Shareholder Alert: May 5, 2026 Lead Plaintiff Deadline in Soleno Therapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm March 13, 2026 9:00 AM - Globe NewsWire Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO March 12, 2026 4:40 AM - PR NewsWire Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO March 11, 2026 9:36 PM - Globe NewsWire Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline March 10, 2026 10:35 PM - Globe NewsWire Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors March 10, 2026 12:00 AM - Globe NewsWire Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO) March 9, 2026 12:44 PM - Globe NewsWire Full Article List